Infinity Pharmaceuticals, Inc. Patent Applications Rejected
7 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2023-11-22: Application 18517460; Invention FORMULATIONS OF (S)-3-(1-(9H-PURIN-6-YLAMINO)ETHYL)-8-CHLORO-2 PHENYLISOQUINOLIN-1(2H)-ONE; Applicant Infinity Pharmaceuticals, Inc.; Status Abandoned -- Incomplete Application (Pre-examination).
- 2023-03-09: Application 18119521; Invention COMBINATION THERAPIES; Applicant Infinity Pharmaceuticals, Inc.; Status Abandoned -- Incomplete Application (Pre-examination).
- 2022-12-12: Application 18064880; Invention TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS; Applicant Infinity Pharmaceuticals, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
- 2022-07-25: Application 17872745; Invention COMBINATION THERAPIES; Applicant Infinity Pharmaceuticals, Inc.; Status Abandoned -- Incomplete Application (Pre-examination).
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2023-11-22 | 18517460 | FORMULATIONS OF (S)-3-(1-(9H-PURIN-6-YLAMINO)ETHYL)-8-CHLORO-2 PHENYLISOQUINOLIN-1(2H)-ONE | Infinity Pharmaceuticals, Inc. | Abandoned -- Incomplete Application (Pre-examination) | Pingda REN Michael MARTIN Paul ISBESTER Benjamin S. LANE Jason KROPP | United States United States United States United States United States | ||
| 2023-03-09 | 18119521 | COMBINATION THERAPIES | Infinity Pharmaceuticals, Inc. | Abandoned -- Incomplete Application (Pre-examination) | Jeffery L. KUTOK Howard M. STERN | United States United States | ||
| 2022-12-12 | 18064880 | TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS | Infinity Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20230364097A1 | Howard M. STERN Jeffery L. Kutok | United States United States | REDDIG, PETER J |
| 2022-07-25 | 17872745 | COMBINATION THERAPIES | Infinity Pharmaceuticals, Inc. | Abandoned -- Incomplete Application (Pre-examination) | Jeffery L. KUTOK Howard M. STERN | United States United States | ||
| 2022-03-21 | 17699582 | FORMULATIONS OF (S)-3-(1-(9H-PURIN-6-YLAMINO)ETHYL)-8-CHLORO-2-PHENYLISOQUINOLIN-1(2H)-ONE | Infinity Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20230108157A1 | Pingda Ren Michael Martin Paul Isbester Benjamin S. Lane Jason Kropp | United States United States United States United States United States | NEAGU, IRINA |
| 2021-09-14 | 17474282 | COMBINATION THERAPIES | Infinity Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20220241287A1 | Jeffery L. KUTOK | United States | HUFF, SHEELA JITENDRA |
| 2019-05-20 | 16417420 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | Infinity Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20190367521A1 | Alfredo C. Castro Catherine A. Evans Somarajannair Janardanannair Andre Lescarbeau Tao Liu Martin R. Tremblay | United States United States United States United States United States United States | BERNHARDT, EMILY A |